Bleeding risk higher with rivaroxaban than dabigatran for stroke prevention, head-to-head trial shows
- PMID: 27702757
- DOI: 10.1136/bmj.i5362
Bleeding risk higher with rivaroxaban than dabigatran for stroke prevention, head-to-head trial shows
Comment on
-
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.JAMA Intern Med. 2016 Nov 1;176(11):1662-1671. doi: 10.1001/jamainternmed.2016.5954. JAMA Intern Med. 2016. PMID: 27695821
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources